Independent Advisor Alliance Has $593,000 Holdings in Humana Inc. (NYSE:HUM)

Independent Advisor Alliance increased its holdings in shares of Humana Inc. (NYSE:HUM) by 9.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,338 shares of the insurance provider’s stock after buying an additional 197 shares during the quarter. Independent Advisor Alliance’s holdings in Humana were worth $593,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in HUM. FPC Investment Advisory Inc. acquired a new stake in Humana during the 4th quarter worth $27,000. Centricity Wealth Management LLC acquired a new stake in shares of Humana during the fourth quarter worth $30,000. OFI Invest Asset Management acquired a new stake in shares of Humana during the fourth quarter worth $33,000. Atwood & Palmer Inc. raised its holdings in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 60 shares during the period. Finally, Kestra Investment Management LLC acquired a new stake in shares of Humana during the fourth quarter worth $49,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

Shares of NYSE HUM opened at $253.11 on Monday. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a market capitalization of $30.55 billion, a P/E ratio of 25.44, a P/E/G ratio of 2.05 and a beta of 0.57. The stock has a 50 day moving average of $271.37 and a 200-day moving average of $279.50. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio is presently 35.58%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Barclays raised their price objective on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. JPMorgan Chase & Co. lowered their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Royal Bank of Canada reiterated an “outperform” rating and issued a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Finally, StockNews.com downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 5th. Nineteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and a consensus target price of $285.68.

Insider Transactions at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.32% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.